Smart Inhalers Market is expected to reach US$ 8,033.21 Mn in 2027

by Sameer Joshi or 14-Jun-2019
     Request For Sample

Report : Smart Inhalers Market to 2027 - Global Analysis and Forecasts By Product (Nebulizers and Inhalers); Disorder (Chronic Obstructive Pulmonary Disease (COPD) and Asthma); End User (Home-Care Settings and Hospitals & Clinics) and Geography

Asthma segment is expected to drive the growth of the global smart inhalers market by disorder

According to a new market research study titled ‘Smart Inhalers market to 2027 – Global Analysis and Forecasts by Product, Disorder and End User.’ The global smart inhalers market is expected to reach US$ 8,033.21 Mn in 2027 from US$ 1,094.26 Mn in 2018. The market is estimated to grow with a CAGR of 25.5% from 2019-2027. The report highlights the trends prevalent in the global smart inhalers market and the factors driving the market along with those that act as deterrents to its growth.

Smart inhalers are advanced form off inhalers that are digitally connected to apps on phone or tablet, which helps the physicians to manage patient’s medical condition more effectively. Smart inhalers use Bluetooth technology to identify the use of inhaler as well as remind patients to take their medication and gather data to help guide care. Other than the management of respiratory diseases, the device also sends an alert on smartphones when a patient enters high pollen or highly polluted area, which helps a patient decide whether to avoid the environment. Smart inhalers have sensors, enabling the patients to automatically track how often the inhaler is being used by the patient, hence avoiding the chances of any human errors.

Global smart inhalers market, based on disorder, was segmented as, asthma and chronic obstructive pulmonary disease (COPD). During 2018, the segment of asthma led the market by the disorder. In addition, the segment is also expected to grow at a significant rate, owing to the increasing prevalence of asthma among individuals across the globe.

The major players operating in the smart inhalers market are, GlaxoSmithKline plc, Adherium Ltd., Vectura Group plc, Novartis AG, Findair Sp. z o. o., Cohero Health, Crux Product Design Ltd, Teva Pharmaceuticals, 3M, and Amiko Digital Health Limited. Organic activities such as product launches have been undertaken by the players in the market in order to improve their position in the smart inhalers market. For instance, in December 2016, Cohero Health and H&T Presspart launched connected metered dose inhaler (eMDI) provide optimized care of patients with asthma and COPD.

The report segments the global Smart inhalers market as follows:

Global Smart Inhalers Market – By Product

  • Inhalers
  • Nebulizers

Global Smart Inhalers Market – By Disorder

  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)

Global Smart Inhalers Market – By End User

  • Home-Care Settings
  • Hospitals & Clinics

Global Smart Inhalers Market – By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • U.K
    • Italy
    • Spain
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • U.A.E
    • South Africa
  • South & Central America (SCAM)
    • Brazil
    • Argentina

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: